Decibel Therapeutics logo
Decibel Therapeutics DBTX
$ 4.91 0.0%

Quarterly report 2023-Q2
added 08-11-2023

report update icon

Decibel Therapeutics Income Statement 2011-2024 | DBTX

Annual Income Statement Decibel Therapeutics

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

102 M 93.5 M - - - - - - - - - -

Shares

25 M 21.7 M - - - - - - - - - -

Historical Prices

4.09 4.3 - - - - - - - - - -

Net Income

-63 M -51.8 M -39.3 M -42.7 M -36.2 M - - - - - - -

Revenue

- - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - -

Operating Income

-64 M -50.2 M -39.6 M - - - - - - - - -

Interest Expense

- - - - - - - - - - - -

EBITDA

-62.5 M -48.8 M -39.6 M -42.3 M -36.4 M - - - - - - -

Operating Expenses

64 M 50.2 M 39.6 M - - - - - - - - -

General and Administrative Expenses

23.6 M 20.4 M 14.2 M 14.7 M 11.7 M - - - - - - -

All numbers in USD currency

Quarterly Income Statement Decibel Therapeutics

2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

25 M 25 M 25 M 25 M 25 M 25 M 25 M 24.9 M 24.9 M 12.1 M 521 K 488 K 469 K 449 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-18.1 M -13.3 M - -16 M -17 M -14 M - -16.4 M -11.7 M -10.9 M - -7.11 M -7.81 M -11.5 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-19 M -14.1 M - -16.3 M -17.1 M -14 M - -14.7 M -11.7 M -10.9 M - -7.09 M -7.85 M -11.6 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- -13.8 M - -15.3 M -16.4 M -13.7 M - -13.6 M -11 M -10.5 M - -5.79 M -6.95 M -11.1 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

19 M 14.1 M - 16.3 M 17.1 M 14 M - 14.7 M 11.7 M 10.9 M - 7.09 M 7.85 M 11.6 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

6.21 M 6.19 M - 6.32 M 5.86 M 6.55 M - 5.68 M 4.9 M 4.88 M - 2.4 M 2.56 M 4.18 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency